Skip to main content
Top
Published in: Archives of Virology 3/2011

01-03-2011 | Brief Report

Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5

Authors: Andreas Sauerbrei, Nadine Wiesener, Roland Zell, Peter Wutzler

Published in: Archives of Virology | Issue 3/2011

Login to get access

Abstract

Eighty-six varicella-zoster virus (VZV) strains of clades 1, 3 and 5, isolated from varicella and zoster patients in Germany, were analyzed by sequencing the glycoprotein E gene. Four novel non-synonymous and 10 novel synonymous mutations were detected. Of these, two synonymous (C513T, C885T) and two non-synonymous mutations (T485G, C524T) were located within the coding regions of e1 and c1. The profile of single-nucleotide polymorphisms was found to be significantly associated with the VZV clades 1, 3 and 5.
Literature
1.
go back to reference McGeoch DJ, Cook S (1994) Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J Mol Biol 238:9–22PubMedCrossRef McGeoch DJ, Cook S (1994) Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J Mol Biol 238:9–22PubMedCrossRef
2.
go back to reference Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010) A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol 91:821–828PubMedCrossRef Breuer J, Grose C, Norberg P, Tipples G, Schmid DS (2010) A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24–25 July 2008. J Gen Virol 91:821–828PubMedCrossRef
3.
go back to reference Mo C, Lee J, Sommer M, Grose C, Arvin AM (2002) The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology 304:176–186PubMedCrossRef Mo C, Lee J, Sommer M, Grose C, Arvin AM (2002) The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology 304:176–186PubMedCrossRef
4.
go back to reference Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V (2000) Stability of a varicella-zoster glycoprotein E epitope. Arch Virol 145:85–97PubMedCrossRef Vafai A, Forghani B, Kilpatrick D, Ling J, Shankar V (2000) Stability of a varicella-zoster glycoprotein E epitope. Arch Virol 145:85–97PubMedCrossRef
5.
go back to reference Santos RA, Padilla JA, Hatfield C, Grose C (1998) Antigenic variation of a varicella-zoster virus Fc receptor gE: loss of major B cell epitope in the ectodomain. Virology 249:21–31PubMedCrossRef Santos RA, Padilla JA, Hatfield C, Grose C (1998) Antigenic variation of a varicella-zoster virus Fc receptor gE: loss of major B cell epitope in the ectodomain. Virology 249:21–31PubMedCrossRef
6.
go back to reference Tipples GA, Stephens GM, Sherlock C, Bowler M, Hoy B, Cook D, Grose C (2002) New variant of varicella-zoster virus. Emerg Infect Dis 8:1504–1505PubMed Tipples GA, Stephens GM, Sherlock C, Bowler M, Hoy B, Cook D, Grose C (2002) New variant of varicella-zoster virus. Emerg Infect Dis 8:1504–1505PubMed
7.
go back to reference Santos RA, Hatfield CC, Cole NL, Padilla JA, Moffat JF, Arvin AA, Ruyechan WT, Hay J, Grose C (2000) Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 275:306–317PubMedCrossRef Santos RA, Hatfield CC, Cole NL, Padilla JA, Moffat JF, Arvin AA, Ruyechan WT, Hay J, Grose C (2000) Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology 275:306–317PubMedCrossRef
8.
go back to reference Natoli S, Ciotti M, Paba P, Testore GP, Palmieri G, Orlandi A, Sabato AF, Leonardis F (2006) A novel mutation of varicella-zoster virus associated to fatal hepatitis. J Clin Virol 37:72–74PubMedCrossRef Natoli S, Ciotti M, Paba P, Testore GP, Palmieri G, Orlandi A, Sabato AF, Leonardis F (2006) A novel mutation of varicella-zoster virus associated to fatal hepatitis. J Clin Virol 37:72–74PubMedCrossRef
9.
go back to reference Wigart BZ, Estrada V, Jockson W, Linde A, Grose C (2006) A novel varicella-zoster virus gE mutation discovered in two Swedish isolates. J Clin Virol 37:134–136CrossRef Wigart BZ, Estrada V, Jockson W, Linde A, Grose C (2006) A novel varicella-zoster virus gE mutation discovered in two Swedish isolates. J Clin Virol 37:134–136CrossRef
10.
go back to reference Shankar V, Fisher S, Forghani B, Vafai A (2001) Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions. Vaccine 19:3830–3833PubMedCrossRef Shankar V, Fisher S, Forghani B, Vafai A (2001) Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions. Vaccine 19:3830–3833PubMedCrossRef
11.
go back to reference Schmidt-Chanasit J, Bleymehl K, Schäd SG, Gross G, Ulrich RG, Doerr HW (2008) Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol 46:325–327PubMedCrossRef Schmidt-Chanasit J, Bleymehl K, Schäd SG, Gross G, Ulrich RG, Doerr HW (2008) Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J Clin Microbiol 46:325–327PubMedCrossRef
12.
go back to reference Sauerbrei A, Zell R, Philipps A, Wutzler P (2008) Genotypes of varicella-zoster virus wild-type strains in Germany. J Med Virol 80:1123–1130PubMedCrossRef Sauerbrei A, Zell R, Philipps A, Wutzler P (2008) Genotypes of varicella-zoster virus wild-type strains in Germany. J Med Virol 80:1123–1130PubMedCrossRef
13.
go back to reference Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R, Wutzler P (2010) Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol. doi:10.1007/s00430-010-0178-6 Sauerbrei A, Stefanski J, Philipps A, Krumbholz A, Zell R, Wutzler P (2010) Monitoring prevalence of varicella-zoster virus clades in Germany. Med Microbiol Immunol. doi:10.​1007/​s00430-010-0178-6
14.
go back to reference Sauerbrei A, Zell R, Harder M, Wutzler P (2006) Genotyping of different varicella vaccine strains. J Clin Virol 37:109–117PubMedCrossRef Sauerbrei A, Zell R, Harder M, Wutzler P (2006) Genotyping of different varicella vaccine strains. J Clin Virol 37:109–117PubMedCrossRef
15.
go back to reference Sauerbrei A, Bohn K, Zell R, Wutzler P (2009) Variability of the immediate early gene 62 in German varicella-zoster virus wild-type strains. J Clin Microbiol 47:3717–3720PubMedCrossRef Sauerbrei A, Bohn K, Zell R, Wutzler P (2009) Variability of the immediate early gene 62 in German varicella-zoster virus wild-type strains. J Clin Microbiol 47:3717–3720PubMedCrossRef
16.
go back to reference Faga B, Maury W, Bruckner DA, Grose C (2001) Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 280:1–6PubMedCrossRef Faga B, Maury W, Bruckner DA, Grose C (2001) Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 280:1–6PubMedCrossRef
17.
go back to reference Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C (2003) The out of Africa model of varicella-zoster virus evolution: Single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072–1081PubMedCrossRef Wagenaar TR, Chow VT, Buranathai C, Thawatsupha P, Grose C (2003) The out of Africa model of varicella-zoster virus evolution: Single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 21:1072–1081PubMedCrossRef
Metadata
Title
Sequence analysis of the glycoprotein E gene of varicella-zoster virus strains of clades 1, 3 and 5
Authors
Andreas Sauerbrei
Nadine Wiesener
Roland Zell
Peter Wutzler
Publication date
01-03-2011
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2011
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-010-0864-0

Other articles of this Issue 3/2011

Archives of Virology 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine